HUP9900911A1 - Gyógyászatilag hatásos zsírsavszármazékok, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítmények - Google Patents
Gyógyászatilag hatásos zsírsavszármazékok, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítményekInfo
- Publication number
- HUP9900911A1 HUP9900911A1 HU9900911A HUP9900911A HUP9900911A1 HU P9900911 A1 HUP9900911 A1 HU P9900911A1 HU 9900911 A HU9900911 A HU 9900911A HU P9900911 A HUP9900911 A HU P9900911A HU P9900911 A1 HUP9900911 A1 HU P9900911A1
- Authority
- HU
- Hungary
- Prior art keywords
- ring
- powder
- general formula
- chain alkyl
- acyl
- Prior art date
Links
- 150000001408 amides Chemical class 0.000 title 1
- 150000002148 esters Chemical class 0.000 title 1
- 239000003358 phospholipase A2 inhibitor Substances 0.000 title 1
- 239000000843 powder Substances 0.000 abstract 6
- 125000002252 acyl group Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
A találmány tárgyát az (I) általánős képletű vegyületek és ezekgyógyászatilag megfelelő sói képezik, ahől a képletben R1 jelentéseacilcsőpőrt, R2 jelentése acil-(rövid szénláncú alkil)-csőpőrt, R3jelentése hidrőgénatőm, aril-(rövid szénláncú alkil)-csőpőrt éshasőnló csőpőrtők, R4 jelentése acil-(rövid szénláncú alkil)-csőpőrt, és R5 Xjelentése -O-, -NH- vagy -N- általánős képletű csőpőrt, ahől aképletben R6 jelentése rövid szénláncú alkilcsőpőrt és hasőnlócsőpőrtők. Az (I) általánős képletű vegyületek kedvező gyógyászatihatásűk következtében gyógyszerek hatóanyagát képezhetik. A találmánytárgyáhőz tartőzik az (I) általánős képletű zsírsavszármazékők és ezeksóinak előállítására szőlgáló eljárás is. A találmány szerintigyógyászati készítmények hatóanyagként valamely (I) általánős képletűzsírsavszármazékőt vagy ennek gyógyászatilag megfelelő sóját, tővábbágyógyászatilag megfelelő vivő- és/vagy segédanyagőt tartalmaznak. ŕ
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9515162.7A GB9515162D0 (en) | 1995-07-24 | 1995-07-24 | New compound |
AUPN9835A AUPN983596A0 (en) | 1996-05-14 | 1996-05-14 | New compound |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9900911A1 true HUP9900911A1 (hu) | 1999-07-28 |
HUP9900911A3 HUP9900911A3 (en) | 2000-06-28 |
Family
ID=25645172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9900911A HUP9900911A3 (en) | 1995-07-24 | 1996-07-18 | Esters and amides as pla2 inhibitors |
Country Status (14)
Country | Link |
---|---|
US (3) | US20020019416A1 (hu) |
EP (1) | EP0854863B1 (hu) |
JP (1) | JP3353301B2 (hu) |
KR (1) | KR19990035780A (hu) |
CN (1) | CN1056602C (hu) |
AT (1) | ATE226934T1 (hu) |
CA (1) | CA2227466A1 (hu) |
DE (1) | DE69624582T2 (hu) |
EA (1) | EA199800155A1 (hu) |
ES (1) | ES2181901T3 (hu) |
HU (1) | HUP9900911A3 (hu) |
IL (1) | IL122664A (hu) |
MX (1) | MX9800704A (hu) |
WO (1) | WO1997003951A1 (hu) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001501980A (ja) * | 1998-06-29 | 2001-02-13 | 藤沢薬品工業株式会社 | 医薬組成物 |
DE19952146A1 (de) * | 1999-10-29 | 2001-06-07 | Boehringer Ingelheim Pharma | Arylalkane, Arylalkene und Aryl-azaalkane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
JP2004503604A (ja) | 2000-07-24 | 2004-02-05 | ザ・ユニバーシティ・オブ・クイーンズランド | 化合物およびホスホリパーゼ阻害剤 |
AU2001272234B2 (en) * | 2000-07-24 | 2006-06-01 | The University Of Queensland | Compounds and inhibitors of phospholipases |
WO2003076389A1 (en) * | 2002-03-07 | 2003-09-18 | The Regents Of The University Of California | Compositions and methods for inhibition of phospholipase a2 mediated inflammation |
US8138383B2 (en) * | 2002-03-11 | 2012-03-20 | Arrowhead Madison Inc. | Membrane active heteropolymers |
US7531569B2 (en) * | 2003-12-02 | 2009-05-12 | Sanofi-Aventis Deutschland Gmbh | Process for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives |
EP1902014A2 (en) | 2005-07-11 | 2008-03-26 | Wyeth | Glutamate aggrecanase inhibitors |
WO2007044100A1 (en) | 2005-10-13 | 2007-04-19 | Wyeth | Methods for preparing glutamic acid derivatives |
FR2893873B1 (fr) * | 2005-11-25 | 2008-12-12 | Air Liquide | Procede de coupage avec un laser a fibre d'acier inoxydable |
JP5584518B2 (ja) * | 2009-05-28 | 2014-09-03 | 石原産業株式会社 | ジアミノトリフルオロメチルピリジン誘導体を含有する抗ショック剤 |
JP6326825B2 (ja) * | 2013-02-18 | 2018-05-23 | 住友化学株式会社 | 塩、レジスト組成物及びレジストパターンの製造方法 |
EP3189033B1 (en) * | 2014-06-19 | 2020-08-05 | Rafael Pharmaceuticals, Inc. | Pharmaceutical compounds |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5128A (en) * | 1847-05-22 | Brick-press | ||
US4792555A (en) * | 1987-03-20 | 1988-12-20 | American Home Products Corporation | Phospholipase A2 inhibitors |
US5128346A (en) * | 1987-09-21 | 1992-07-07 | Abbott Laboratories | Derivatives of D-glutamic acid and D-aspartic acid |
ES2044781B1 (es) * | 1992-04-14 | 1994-10-01 | Menarini Lab | Procedimiento para la preparacion de nuevas amidas con accion inhibidora de la fosfolipasa a2 |
ATE184593T1 (de) * | 1994-01-24 | 1999-10-15 | Fujisawa Pharmaceutical Co | Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren |
-
1996
- 1996-07-18 JP JP50653897A patent/JP3353301B2/ja not_active Expired - Fee Related
- 1996-07-18 WO PCT/JP1996/001995 patent/WO1997003951A1/en not_active Application Discontinuation
- 1996-07-18 EA EA199800155A patent/EA199800155A1/ru unknown
- 1996-07-18 DE DE69624582T patent/DE69624582T2/de not_active Expired - Fee Related
- 1996-07-18 EP EP96924136A patent/EP0854863B1/en not_active Expired - Lifetime
- 1996-07-18 MX MX9800704A patent/MX9800704A/es unknown
- 1996-07-18 IL IL12266496A patent/IL122664A/xx not_active IP Right Cessation
- 1996-07-18 CN CN96197164A patent/CN1056602C/zh not_active Expired - Fee Related
- 1996-07-18 ES ES96924136T patent/ES2181901T3/es not_active Expired - Lifetime
- 1996-07-18 KR KR1019980700439A patent/KR19990035780A/ko not_active Application Discontinuation
- 1996-07-18 US US08/981,830 patent/US20020019416A1/en not_active Abandoned
- 1996-07-18 HU HU9900911A patent/HUP9900911A3/hu unknown
- 1996-07-18 AT AT96924136T patent/ATE226934T1/de not_active IP Right Cessation
- 1996-07-18 CA CA002227466A patent/CA2227466A1/en not_active Abandoned
-
2002
- 2002-05-06 US US10/138,637 patent/US20020169326A1/en not_active Abandoned
-
2003
- 2003-09-22 US US10/665,466 patent/US20040063959A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN1056602C (zh) | 2000-09-20 |
US20020169326A1 (en) | 2002-11-14 |
EA199800155A1 (ru) | 1999-02-25 |
US20020019416A1 (en) | 2002-02-14 |
MX9800704A (es) | 1998-04-30 |
DE69624582T2 (de) | 2003-03-20 |
US20040063959A1 (en) | 2004-04-01 |
IL122664A (en) | 2000-12-06 |
EP0854863A1 (en) | 1998-07-29 |
JP3353301B2 (ja) | 2002-12-03 |
CN1197450A (zh) | 1998-10-28 |
EP0854863B1 (en) | 2002-10-30 |
CA2227466A1 (en) | 1997-02-06 |
HUP9900911A3 (en) | 2000-06-28 |
ES2181901T3 (es) | 2003-03-01 |
JPH11509548A (ja) | 1999-08-24 |
DE69624582D1 (de) | 2002-12-05 |
IL122664A0 (en) | 1998-08-16 |
ATE226934T1 (de) | 2002-11-15 |
KR19990035780A (ko) | 1999-05-25 |
WO1997003951A1 (en) | 1997-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9900911A1 (hu) | Gyógyászatilag hatásos zsírsavszármazékok, eljárás ezek előállítására és ezeket tartalmazó gyógyászati készítmények | |
ES8306726A1 (es) | "procedimiento para la preparacion de derivados de benzazepina". | |
ATE185807T1 (de) | Thiazolylbenzofuranderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die sie enthalten | |
GEP19960467B (en) | Method of producing derivatives of quinoline or their pharmaceutically acceptable esters or acid-additive salts | |
HUP9901079A2 (hu) | 5- és 6-Tagú nitrogéntartalmú gyűrűs vegyületek, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP0000214A2 (hu) | Alfa-szubsztituált benzolszulfonamido-hidroxámsavak, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények | |
ATE188216T1 (de) | Therapeutische mittel für die parkinsonsche krankheit | |
ES8705865A1 (es) | Procedimiento para preparar derivados de becimidazol sustituidos en posicion 5 | |
NO178697C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrazolopyridin-forbindelser | |
ATE14579T1 (de) | Pharmazeutische heterocyclische verbindungen, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen. | |
HUP0105108A2 (hu) | Amidvegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP9801676A2 (hu) | Új 2,3-dioxo-1,2,3,4-tetrahidrokinoxalinil-származékok | |
HUP9900851A2 (hu) | Benzotiofénszármazékok felhasználása véredény simaizom sejtek migrálásának inhibiálására alkalmas gyógyszerkészítmények előállítására | |
HUP9601176A2 (hu) | Adhéziós receptor antagonista amidinszármazékok, az ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra | |
ATE61340T1 (de) | Aminosaeurederivate und deren verfahren zur herstellung. | |
HUT63615A (en) | Process for producing new imidazole derivatives and pharmaceutical compositions comprising same as active ingredient | |
HUP9701660A2 (hu) | 10,13,15-trioxa-triciklo[9.2.1.1. 9.6]pentadekanon-származékok, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények | |
AU1466295A (en) | Amino acid derivatives and their use as phospholipase a2 inhibitors | |
ES8604102A1 (es) | Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo dialquilaminoalcoxi sustituido y de sus sa-les de adicion acidas y amonicas cuaternarias | |
AU4583489A (en) | New indole derivatives, process for preparing them and pharmaceutical compositions containing them | |
HUP9701300A1 (hu) | Új biszimidszármazékok, eljárás előállításukra, és ezeket tartalmazó gyógyászati készítmények | |
HUP0104949A2 (hu) | Antibakteriális hatású higromicinszármazékok és eljárás előállításukra, valamint az ezeket tartalmazó gyógyszerkészítmények | |
HUP9801985A2 (hu) | Cisztinszármazékok alkalmazása restenózis gyógyítására használható gyógyszerkészítmények előállítására | |
ES8600203A1 (es) | Procedimiento de preparacion de nuevos derivados aminoetoxibencilalcoholicos y de sus sales de adicion acidas y amonicas cuaternarias | |
BR1100549A (pt) | Derivados de penem, processo para sua preparação, e, composições farmacêuticas. |